U S Physical Therapy (USPH) FY2013 results: revenue $264 million, up 5.8% on the year
U S Physical Therapy Inc. (USPH) reported revenue of $264 million for fiscal 2013, the year ended 31 December 2013, up 5.8% on the year before. Net income was $13 million, down 29.1%, and diluted earnings per share $1.05. The figures are the company's own, from the 10-K it filed with the SEC on 11 March 2014.
Revenue
$264 million
+5.8% on the year
FY2009FY2013
Operating margin
14.7%
15.4% a year earlier
FY2009FY2013
Net income
$13 million
-29.1% on the year
FY2009FY2013
Diluted EPS
$1.05
-30.5% on the year
FY2009FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
264
250
232
+5.8%
Gross profit
64.7
62.9
55.9
+2.8%
Gross margin
24.5%
25.2%
24.1%
Selling, general and administrative
25.9
n/a
n/a
Operating income
38.8
38.4
31.4
+0.9%
Operating margin
14.7%
15.4%
13.6%
Interest expense
0.5
0.6
0.5
-3.4%
Pre-tax income
38.2
37.9
36.4
+1.0%
Income tax
12.2
11.2
9.7
+9.1%
Effective tax rate
32.0%
29.6%
26.7%
Net income
12.7
17.9
21.0
-29.1%
Net margin
4.8%
7.2%
9.1%
Diluted EPS
$1.05
$1.51
$1.75
-30.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
44.8
39.2
32.7
+14.1%
Capital expenditure
4.6
4.2
3.2
+9.5%
Free cash flow
40.2
35.0
29.4
+14.7%
Free cash flow margin
15.2%
14.0%
12.7%
Cash from investing
-52.4
-14.1
-31.6
Cash from financing
8.9
-23.5
-0.2
Depreciation and amortisation
5.6
5.3
5.4
+5.2%
Share-based compensation
2.7
2.1
2.0
+30.5%
Buybacks
n/a
n/a
4.7
Dividends paid
4.8
9.0
3.8
-46.3%
Dividend per share
$0.40
$0.76
$0.32
-47.4%
Diluted shares, weighted
12m
12m
12m
+1.5%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
128
117
107
+9.3%
Non-controlling interest
22.7
17.3
14.5
+31.1%
Redeemable equity
4.1
n/a
n/a
Debt
41.5
18.0
24.2
+130.0%
Other liabilities
27.5
19.0
17.5
+44.8%
Total liabilities and equity
224
172
163
+30.5%
Fixed assets
15.0
13.0
13.2
+14.9%
Goodwill
144
100
92.8
+43.7%
Intangible assets
14.5
12.1
9.6
+19.2%
Cash and equivalents
12.9
11.7
10.0
+10.5%
Other assets
37.8
34.7
37.7
+9.1%
Total assets
224
172
163
+30.5%
10-K for the year ended 31 December 2013, filed 11 March 2014: the filing.